Skip to main content
. 1999 May;43(5):1067–1071. doi: 10.1128/aac.43.5.1067

FIG. 3.

FIG. 3

Gatifloxacin (400 mg) plasma concentration-time curves and urinary recovery levels for treatments D to F (group 2) determined by HPLC. ○, group 2, treatment D, gatifloxacin alone; ■, group 2, treatment E, gatifloxacin and two aluminum magnesium hydroxide single-use flasks 2 h after gatifloxacin; ⧫, group 2, treatment F, gatifloxacin and two aluminum magnesium hydroxide single-use flasks 4 h after gatifloxacin.